×
About 22,266 results

ALLMedicine™ Congestive Heart Failure Center

Research & Reviews  9,109 results

Performance of Emergency Heart Failure Mortality Risk Grade in the Emergency Department.
https://doi.org/10.5811/westjem.2021.1.48978
The Western Journal of Emergency Medicine; Garg N, Pekmezaris R et. al.

Jun 14th, 2021 - The purpose of this study was to validate and assess the performance of the Emergency Heart Failure Mortality Risk Grade (EHMRG) to predict seven-day mortality in US patients presenting to the emergency department (ED) with acute congestive heart ...

Paramedic-performed Prehospital Point-of-care Ultrasound for Patients with Undifferenti...
https://doi.org/10.5811/westjem.2020.12.49254
The Western Journal of Emergency Medicine; Schoeneck JH, Coughlin RF et. al.

Jun 14th, 2021 - Thoracic ultrasound is frequently used in the emergency department (ED) to determine the etiology of dyspnea, yet its use is not widespread in the prehospital setting. We sought to investigate the feasibility and diagnostic performance of paramedi...

5-ITEM MODIFIED FRAILTY INDEX AS A PREOPERATIVE PREDICTOR OF MORBIDITY FOLLOWING MINIMA...
https://doi.org/10.1016/j.urology.2021.05.050
Urology Goldwag J, Harris A et. al.

Jun 13th, 2021 - To apply the modified frailty index-5 (mFI-5) to those patients undergoing minimally invasive partial nephrectomy (MIPN) to examine the relationship between frailty and postoperative outcomes. Using the American College of Surgeons National Surgic...

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic revie...
https://doi.org/10.1186/s13054-021-03585-7 10.1053/j.ackd.2011.01.008 10.3109/15563650.2012.683436 10.1681/ASN.2020050564 10.1080/15563650.2016.1209768 10.1081/CLT-100102018 10.1016/0002-8703(91)90735-Z 10.1177/106002809703100709 10.1097/00000542-199507000-00025 10.1177/096032718600500510 10.1007/BF03161225 10.1002/cpt1977225part1557 10.1111/j.1365-2125.1978.tb04617.x 10.1080/15563650.2020.1834219 10.1081/CLT-100100932 10.3109/15563650.2010.534483 10.1016/0736-4679(94)90487-1 10.3109/15563659609013789 10.1081/CLT-62475 10.1016/S0196-0644(84)80337-6 10.1001/archinte.1987.00370010043011 10.1097/00006565-199908000-00007 10.1016/S0300-9572(98)00146-4 10.1007/s00390-005-0517-9 10.1191/0960327106ht632oa 10.1016/0735-6757(94)90160-0 10.1111/j.1600-0773.1979.tb02360.x 10.1016/0002-9149(86)90692-2 10.1159/000316050 10.1111/bcp.12201 10.1067/mem.2002.129829 10.1080/15563650.2019.1677022 10.1007/s13181-012-0281-8 10.1016/j.reaurg.2009.05.004 10.1111/bcp.12763 10.1080/15563650.2017.1284329 10.1111/j.1365-2125.1983.tb01535.x 10.1159/000169307 10.1007/BF03189860 10.1016/0160-5402(86)90062-8 10.1002/jps.2600700336 10.1136/bmj.4.5888.320 10.1002/cpt1974165part1761 10.1002/j.1552-4604.1975.tb02379.x 10.2165/00003088-197601050-00004 10.1111/j.1365-2125.1976.tb00601.x 10.1002/cpt1978235606 10.1111/j.1365-2125.1979.tb04694.x 10.1111/j.1365-2125.1980.tb01065.x 10.1007/978-3-642-67729-8_79 10.1007/BF00558446 10.1038/clpt.1980.105 10.2165/00003088-198005020-00006 10.1038/clpt.1981.63 10.1007/BF00558387 10.1007/BF00549590 10.1016/0002-8703(84)90587-8 10.1111/j.1365-2125.1984.tb02490.x 10.1002/j.1552-4604.1985.tb02864.x 10.1038/clpt.1986.207 10.1093/eurheartj/8.suppl_M.15 10.1038/clpt.1989.35 10.1177/039139889902201204 10.5414/CPP39061 10.2215/CJN.07470717 10.1016/S0196-0644(86)80622-9 10.1080/15563658809167103 10.1097/00003246-199101000-00026 10.1002/j.1552-4604.1996.tb04247.x 10.1177/089686089701700223 10.1093/ndt/12.2.331 10.1177/0885066607307528 10.3109/15563650903544132 10.4103/0972-5229.128709 10.1016/j.jemermed.2014.04.044 10.4103/0971-4065.133033 10.1007/s13181-014-0419-y 10.1177/1024907918762868 10.1177/106002808101501215 10.1111/sdi.12251 10.1093/ndt/gfw456 10.1001/jama.289.16.2120 10.1016/j.jacc.2006.08.057 10.1002/cpt1977216691 10.1111/sdi.12247 10.1002/cpt1976194416 10.1159/000213115 10.1002/bdd.2510040309 10.1111/j.1365-2125.1980.tb05837.x 10.1111/j.1365-2125.1983.tb02158.x 10.1111/j.1365-2125.1979.tb04644.x 10.1186/s13054-020-02915-5 10.1002/chir.10097 10.1007/BF01065395 10.1111/j.1600-0773.1974.tb00745.x 10.1016/0024-3205(74)90452-4 10.1002/cpt1979254408 10.1038/clpt.1980.166 10.1111/j.1365-2125.1982.tb01364.x 10.1002/j.1552-4604.1983.tb02721.x 10.1038/clpt.1989.198 10.1007/BF00609750 10.1002/cpt1976205524 10.1007/BF00609856 10.1111/j.1365-2125.1980.tb01787.x 10.1002/jps.2600770913 10.1007/BF00606665 10.1002/jps.2600800407 10.1038/clpt.1984.19 10.2165/00003088-198713020-00003 10.1002/j.1552-4604.1986.tb02959.x 10.1007/BF00265912 10.1007/s00228-016-2041-1 10.1097/00005344-199107000-00005 10.1007/s00228-012-1427-y 10.1111/j.1365-2125.1991.tb05596.x 10.1111/j.1365-2125.1986.tb02821.x 10.1038/clpt.1984.130 10.1007/BF00316097 10.1007/BF00265913 10.1007/BF00544023 10.1007/BF00613462 10.1007/BF00544245 10.1007/BF01409476 10.1097/00005344-198710111-00015 10.1097/00005344-199219001-00020 10.1007/s002280050628 10.1007/BF02280760 10.2165/00003495-198734040-00002 10.1016/S0378-4347(00)82586-4 10.1093/jaoac/84.4.1252 10.1067/mcp.2003.26 10.1016/j.clpt.2003.11.002 10.1007/s00228-003-0694-z 10.1002/j.1552-4604.1988.tb05762.x 10.1111/j.1365-2125.1985.tb02663.x 10.1016/S0009-9120(84)80150-2 10.1038/clpt.1983.193 10.1002/j.1552-4604.1987.tb05583.x 10.1097/00007691-199206000-00006 10.1111/j.1365-2125.1979.tb04773.x 10.1097/00007691-198004000-00006 10.1111/j.1365-2125.1982.tb04936.x 10.1016/0002-9149(87)90385-7 10.1111/j.1365-2125.1984.tb02392.x 10.1038/clpt.1983.250 10.1002/bdd.2510040402 10.1055/s-2008-1069864 10.1007/BF00637616 10.1007/BF00315024 10.1007/BF00266359 10.1007/BF01061407 10.2165/00003088-198106050-00004 10.1007/BF00613821 10.1007/BF03188836 10.1007/BF00637630 10.2165/00003088-198005020-00004 10.1097/00005344-198011000-00002 10.1111/j.2042-7158.1984.tb04413.x 10.1002/j.1552-4604.1977.tb04609.x 10.1002/j.1552-4604.1979.tb01641.x 10.1007/BF00542499 10.1111/bcp.12917 10.1007/s002280050194 10.1007/s002280050237 10.1046/j.1365-2125.1997.54212.x 10.1177/0091270010370846 10.1111/jcpt.12180 10.1007/BF03188744 10.1111/j.1365-2125.1985.tb05072.x 10.1016/0009-9236(95)90211-2 10.1002/cpt1976204401 10.1111/j.1365-2125.1985.tb02757.x 10.1111/j.1365-2125.1979.tb00936.x 10.1016/0002-9149(83)90643-4 10.1111/j.1365-2125.1985.tb02754.x 10.1007/BF00315476 10.1007/BF00686119 10.1007/BF00547425 10.1111/j.1365-2125.1977.tb00684.x 10.1002/cpt1979255part1528 10.1007/BF01726915 10.1007/BF00635892 10.1007/BF00637597 10.1007/BF00542123 10.1111/jcpt.12310 10.1038/ki.1979.86 10.1007/BF00614385 10.1002/j.1552-4604.1977.tb05643.x 10.1007/BF01037959 10.1002/cpt1977225part1505 10.1007/BF01037948 10.1038/clpt.1980.187 10.1002/cpt197314126 10.1007/BF00560339 10.1007/BF00607143 10.1007/BF00609892 10.1038/clpt.1983.245 10.1007/BF00544357 10.1007/BF00563552 10.1007/BF00562614 10.1002/cpt1973144part1494 10.1111/j.1365-2125.1980.tb00511.x 10.1038/clpt.1984.107 10.1002/j.1552-4604.1987.tb05582.x 10.1002/jps.2600760706 10.1038/clpt.1989.136 10.1038/clpt.1992.53 10.1111/j.1365-2125.1978.tb00862.x 10.1007/BF00563074 10.1111/j.1365-2125.1979.tb00896.x 10.1038/clpt.1981.162 10.1097/00005344-198503000-00029 10.1007/BF00981142 10.1111/j.1365-2125.1986.tb02837.x 10.1002/bdd.2510070605 10.1038/clpt.1982.223 10.1161/01.CIR.52.2.313 10.1038/clpt.1986.198 10.1111/j.1600-0773.1976.tb03162.x 10.1007/BF00278585 10.1002/j.1552-4604.1997.tb05627.x 10.1002/j.1552-4604.1979.tb02522.x 10.1111/j.2042-7158.1994.tb03865.x 10.1002/bdd.2510160505 10.1002/j.1552-4604.1978.tb01580.x 10.1007/BF00716385 10.1007/BF01061376 10.1002/bdd.2510020213 10.1111/j.1365-2125.1975.tb00551.x 10.1007/BF00609855 10.1056/NEJMoa1500964 10.1007/s00134-019-05651-9 10.1111/aas.13214 10.1053/j.ajkd.2013.07.009 10.1053/j.ajkd.2014.08.013 10.1016/S0272-6386(12)80135-1 10.1046/j.1537-2995.1989.29289146829.x 10.1016/j.ajem.2017.10.048 10.1111/j.1553-2712.1997.tb03758.x
Critical Care (London, England); Bouchard J, Shepherd G et. al.

Jun 11th, 2021 - β-adrenergic antagonists (BAAs) are used to treat cardiovascular disease such as ischemic heart disease, congestive heart failure, dysrhythmias, and hypertension. Poisoning from BAAs can lead to severe morbidity and mortality. We aimed to determin...

A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Ass...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180309
International Journal of Chronic Obstructive Pulmonary Di... Rebordosa C, Plana E et. al.

Jun 9th, 2021 - The long-acting anticholinergic (LAMA) aclidinium was approved in Europe in 2012 to relieve symptoms in adults with chronic obstructive pulmonary disease (COPD). A Post-Authorisation Safety Study (PASS) was initiated to assess potential cardiovasc...

see more →

Guidelines  19 results

AHA's "Life's Simple 7" Reduces Heart Failure Risk
https://www.patientcareonline.com/cardiovascular-disease/ahas-lifes-simple-7-reduces-heart-failure-risk

Jul 24th, 2019 - The incidence of congestive heart failure (HF) was reduced by 47% in a group of individuals adhering to a combination of healthy lifestyle practices; among individuals who adhered to an “ideal” combination of those practices, HF was reduced by 55%...

Lisinopril: Uses, Dosage, Side Effects & Warnings - Drugs.com
https://www.drugs.com/lisinopril.html

Apr 30th, 2019 - Lisinopril is used to treat hypertension, congestive heart failure and to improve survival after a heart attack. Learn about side effects, interactions and indications.

Nitroglycerin - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK482382/
Kim,K.,et al

Mar 1st, 2019 - Nitroglycerin is a vasodilatory drug that is used primarily to provide relief from anginal chest pain. Nitroglycerin has been FDA approved since 2000 and was first sold by Pfizer under the brand name Nitrostat. It is currently FDA approved for the...

Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes and associated complications in people at increased risk of type 2 diabetes
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005061.pub3/full
The Cochrane Database of Systematic Reviews; Moelands,S.,et al

Dec 27th, 2018 - Background Alpha‐glucosidase inhibitors (AGI) reduce blood glucose levels and may thus prevent or delay type 2 diabetes mellitus (T2DM) and its associated complications in people at risk of developing of T2DM. Objectives To assess the effects of ...

Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positiv...
http://ascopubs.org/doi/full/10.1200/JCO.2018.79.2697
Sharon H. Giordano

Sep 9th, 2018 - HER2-targeted therapy is recommended for patients with HER2-positive advanced breast cancer, except for those with clinical congestive heart failure or significantly compromised left ventricular ejection fraction, who should be evaluated on a case.

see more →

Drugs  1,415 results see all →

Clinicaltrials.gov  11,049 results

Performance of Emergency Heart Failure Mortality Risk Grade in the Emergency Department.
https://doi.org/10.5811/westjem.2021.1.48978
The Western Journal of Emergency Medicine; Garg N, Pekmezaris R et. al.

Jun 14th, 2021 - The purpose of this study was to validate and assess the performance of the Emergency Heart Failure Mortality Risk Grade (EHMRG) to predict seven-day mortality in US patients presenting to the emergency department (ED) with acute congestive heart ...

Paramedic-performed Prehospital Point-of-care Ultrasound for Patients with Undifferenti...
https://doi.org/10.5811/westjem.2020.12.49254
The Western Journal of Emergency Medicine; Schoeneck JH, Coughlin RF et. al.

Jun 14th, 2021 - Thoracic ultrasound is frequently used in the emergency department (ED) to determine the etiology of dyspnea, yet its use is not widespread in the prehospital setting. We sought to investigate the feasibility and diagnostic performance of paramedi...

5-ITEM MODIFIED FRAILTY INDEX AS A PREOPERATIVE PREDICTOR OF MORBIDITY FOLLOWING MINIMA...
https://doi.org/10.1016/j.urology.2021.05.050
Urology Goldwag J, Harris A et. al.

Jun 13th, 2021 - To apply the modified frailty index-5 (mFI-5) to those patients undergoing minimally invasive partial nephrectomy (MIPN) to examine the relationship between frailty and postoperative outcomes. Using the American College of Surgeons National Surgic...

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic revie...
https://doi.org/10.1186/s13054-021-03585-7 10.1053/j.ackd.2011.01.008 10.3109/15563650.2012.683436 10.1681/ASN.2020050564 10.1080/15563650.2016.1209768 10.1081/CLT-100102018 10.1016/0002-8703(91)90735-Z 10.1177/106002809703100709 10.1097/00000542-199507000-00025 10.1177/096032718600500510 10.1007/BF03161225 10.1002/cpt1977225part1557 10.1111/j.1365-2125.1978.tb04617.x 10.1080/15563650.2020.1834219 10.1081/CLT-100100932 10.3109/15563650.2010.534483 10.1016/0736-4679(94)90487-1 10.3109/15563659609013789 10.1081/CLT-62475 10.1016/S0196-0644(84)80337-6 10.1001/archinte.1987.00370010043011 10.1097/00006565-199908000-00007 10.1016/S0300-9572(98)00146-4 10.1007/s00390-005-0517-9 10.1191/0960327106ht632oa 10.1016/0735-6757(94)90160-0 10.1111/j.1600-0773.1979.tb02360.x 10.1016/0002-9149(86)90692-2 10.1159/000316050 10.1111/bcp.12201 10.1067/mem.2002.129829 10.1080/15563650.2019.1677022 10.1007/s13181-012-0281-8 10.1016/j.reaurg.2009.05.004 10.1111/bcp.12763 10.1080/15563650.2017.1284329 10.1111/j.1365-2125.1983.tb01535.x 10.1159/000169307 10.1007/BF03189860 10.1016/0160-5402(86)90062-8 10.1002/jps.2600700336 10.1136/bmj.4.5888.320 10.1002/cpt1974165part1761 10.1002/j.1552-4604.1975.tb02379.x 10.2165/00003088-197601050-00004 10.1111/j.1365-2125.1976.tb00601.x 10.1002/cpt1978235606 10.1111/j.1365-2125.1979.tb04694.x 10.1111/j.1365-2125.1980.tb01065.x 10.1007/978-3-642-67729-8_79 10.1007/BF00558446 10.1038/clpt.1980.105 10.2165/00003088-198005020-00006 10.1038/clpt.1981.63 10.1007/BF00558387 10.1007/BF00549590 10.1016/0002-8703(84)90587-8 10.1111/j.1365-2125.1984.tb02490.x 10.1002/j.1552-4604.1985.tb02864.x 10.1038/clpt.1986.207 10.1093/eurheartj/8.suppl_M.15 10.1038/clpt.1989.35 10.1177/039139889902201204 10.5414/CPP39061 10.2215/CJN.07470717 10.1016/S0196-0644(86)80622-9 10.1080/15563658809167103 10.1097/00003246-199101000-00026 10.1002/j.1552-4604.1996.tb04247.x 10.1177/089686089701700223 10.1093/ndt/12.2.331 10.1177/0885066607307528 10.3109/15563650903544132 10.4103/0972-5229.128709 10.1016/j.jemermed.2014.04.044 10.4103/0971-4065.133033 10.1007/s13181-014-0419-y 10.1177/1024907918762868 10.1177/106002808101501215 10.1111/sdi.12251 10.1093/ndt/gfw456 10.1001/jama.289.16.2120 10.1016/j.jacc.2006.08.057 10.1002/cpt1977216691 10.1111/sdi.12247 10.1002/cpt1976194416 10.1159/000213115 10.1002/bdd.2510040309 10.1111/j.1365-2125.1980.tb05837.x 10.1111/j.1365-2125.1983.tb02158.x 10.1111/j.1365-2125.1979.tb04644.x 10.1186/s13054-020-02915-5 10.1002/chir.10097 10.1007/BF01065395 10.1111/j.1600-0773.1974.tb00745.x 10.1016/0024-3205(74)90452-4 10.1002/cpt1979254408 10.1038/clpt.1980.166 10.1111/j.1365-2125.1982.tb01364.x 10.1002/j.1552-4604.1983.tb02721.x 10.1038/clpt.1989.198 10.1007/BF00609750 10.1002/cpt1976205524 10.1007/BF00609856 10.1111/j.1365-2125.1980.tb01787.x 10.1002/jps.2600770913 10.1007/BF00606665 10.1002/jps.2600800407 10.1038/clpt.1984.19 10.2165/00003088-198713020-00003 10.1002/j.1552-4604.1986.tb02959.x 10.1007/BF00265912 10.1007/s00228-016-2041-1 10.1097/00005344-199107000-00005 10.1007/s00228-012-1427-y 10.1111/j.1365-2125.1991.tb05596.x 10.1111/j.1365-2125.1986.tb02821.x 10.1038/clpt.1984.130 10.1007/BF00316097 10.1007/BF00265913 10.1007/BF00544023 10.1007/BF00613462 10.1007/BF00544245 10.1007/BF01409476 10.1097/00005344-198710111-00015 10.1097/00005344-199219001-00020 10.1007/s002280050628 10.1007/BF02280760 10.2165/00003495-198734040-00002 10.1016/S0378-4347(00)82586-4 10.1093/jaoac/84.4.1252 10.1067/mcp.2003.26 10.1016/j.clpt.2003.11.002 10.1007/s00228-003-0694-z 10.1002/j.1552-4604.1988.tb05762.x 10.1111/j.1365-2125.1985.tb02663.x 10.1016/S0009-9120(84)80150-2 10.1038/clpt.1983.193 10.1002/j.1552-4604.1987.tb05583.x 10.1097/00007691-199206000-00006 10.1111/j.1365-2125.1979.tb04773.x 10.1097/00007691-198004000-00006 10.1111/j.1365-2125.1982.tb04936.x 10.1016/0002-9149(87)90385-7 10.1111/j.1365-2125.1984.tb02392.x 10.1038/clpt.1983.250 10.1002/bdd.2510040402 10.1055/s-2008-1069864 10.1007/BF00637616 10.1007/BF00315024 10.1007/BF00266359 10.1007/BF01061407 10.2165/00003088-198106050-00004 10.1007/BF00613821 10.1007/BF03188836 10.1007/BF00637630 10.2165/00003088-198005020-00004 10.1097/00005344-198011000-00002 10.1111/j.2042-7158.1984.tb04413.x 10.1002/j.1552-4604.1977.tb04609.x 10.1002/j.1552-4604.1979.tb01641.x 10.1007/BF00542499 10.1111/bcp.12917 10.1007/s002280050194 10.1007/s002280050237 10.1046/j.1365-2125.1997.54212.x 10.1177/0091270010370846 10.1111/jcpt.12180 10.1007/BF03188744 10.1111/j.1365-2125.1985.tb05072.x 10.1016/0009-9236(95)90211-2 10.1002/cpt1976204401 10.1111/j.1365-2125.1985.tb02757.x 10.1111/j.1365-2125.1979.tb00936.x 10.1016/0002-9149(83)90643-4 10.1111/j.1365-2125.1985.tb02754.x 10.1007/BF00315476 10.1007/BF00686119 10.1007/BF00547425 10.1111/j.1365-2125.1977.tb00684.x 10.1002/cpt1979255part1528 10.1007/BF01726915 10.1007/BF00635892 10.1007/BF00637597 10.1007/BF00542123 10.1111/jcpt.12310 10.1038/ki.1979.86 10.1007/BF00614385 10.1002/j.1552-4604.1977.tb05643.x 10.1007/BF01037959 10.1002/cpt1977225part1505 10.1007/BF01037948 10.1038/clpt.1980.187 10.1002/cpt197314126 10.1007/BF00560339 10.1007/BF00607143 10.1007/BF00609892 10.1038/clpt.1983.245 10.1007/BF00544357 10.1007/BF00563552 10.1007/BF00562614 10.1002/cpt1973144part1494 10.1111/j.1365-2125.1980.tb00511.x 10.1038/clpt.1984.107 10.1002/j.1552-4604.1987.tb05582.x 10.1002/jps.2600760706 10.1038/clpt.1989.136 10.1038/clpt.1992.53 10.1111/j.1365-2125.1978.tb00862.x 10.1007/BF00563074 10.1111/j.1365-2125.1979.tb00896.x 10.1038/clpt.1981.162 10.1097/00005344-198503000-00029 10.1007/BF00981142 10.1111/j.1365-2125.1986.tb02837.x 10.1002/bdd.2510070605 10.1038/clpt.1982.223 10.1161/01.CIR.52.2.313 10.1038/clpt.1986.198 10.1111/j.1600-0773.1976.tb03162.x 10.1007/BF00278585 10.1002/j.1552-4604.1997.tb05627.x 10.1002/j.1552-4604.1979.tb02522.x 10.1111/j.2042-7158.1994.tb03865.x 10.1002/bdd.2510160505 10.1002/j.1552-4604.1978.tb01580.x 10.1007/BF00716385 10.1007/BF01061376 10.1002/bdd.2510020213 10.1111/j.1365-2125.1975.tb00551.x 10.1007/BF00609855 10.1056/NEJMoa1500964 10.1007/s00134-019-05651-9 10.1111/aas.13214 10.1053/j.ajkd.2013.07.009 10.1053/j.ajkd.2014.08.013 10.1016/S0272-6386(12)80135-1 10.1046/j.1537-2995.1989.29289146829.x 10.1016/j.ajem.2017.10.048 10.1111/j.1553-2712.1997.tb03758.x
Critical Care (London, England); Bouchard J, Shepherd G et. al.

Jun 11th, 2021 - β-adrenergic antagonists (BAAs) are used to treat cardiovascular disease such as ischemic heart disease, congestive heart failure, dysrhythmias, and hypertension. Poisoning from BAAs can lead to severe morbidity and mortality. We aimed to determin...

A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Ass...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180309
International Journal of Chronic Obstructive Pulmonary Di... Rebordosa C, Plana E et. al.

Jun 9th, 2021 - The long-acting anticholinergic (LAMA) aclidinium was approved in Europe in 2012 to relieve symptoms in adults with chronic obstructive pulmonary disease (COPD). A Post-Authorisation Safety Study (PASS) was initiated to assess potential cardiovasc...

see more →

News  663 results

Experts Point to Better Ways to Handle Hospital Conflicts
https://www.medscape.com/viewarticle/952083

May 27th, 2021 - Imagine a hospitalist, part of a group with 35 hospitalists, is in her second year of practice and is caring for a 55-year-old woman with a history of congestive heart failure and cirrhosis from hepatitis C due to heroin use. The patient was hospi...

Unhealthy Sleep Behaviours May Increase the Risk of Shortened Healthspan
https://www.medscape.com/viewarticle/951000

May 11th, 2021 - A new prospective cohort study published in the journal  Sleep and Breathing suggests that certain unhealthy sleep behaviours are associated with a higher risk of shortened healthspan. Researchers determined the associations between four sleep beh...

Cardiologist, Antiwar Activist Bernard Lown Dies at 99
https://www.medscape.com/viewarticle/945966

Feb 16th, 2021 - Dr Bernard Lown walks on the bridge renamed in his honor in Lewiston, Maine. BOSTON (AP) — Dr. Bernard Lown, a Massachusetts cardiologist who invented the first reliable heart defibrillator and later co-founded an anti-nuclear war group that was a...

Atrial Fibrillation Clinical Practice Guidelines (ESC/EACTS, 2020)
https://reference.staging.medscape.com/viewarticle/938242

Sep 29th, 2020 - Recommendations for the diagnosis and management of atrial fibrillation (AF) were released in August 2020 by the European Society of Cardiology (ESC) in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).[1,2] Diagnosis...

Atrial Fibrillation Clinical Practice Guidelines (ESC/EACTS, 2020)
https://reference.medscape.com/viewarticle/938242

Sep 29th, 2020 - Recommendations for the diagnosis and management of atrial fibrillation (AF) were released in August 2020 by the European Society of Cardiology (ESC) in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).[1,2] Diagnosis...

see more →

Patient Education  11 results see all →